TengfuJiangya tabletforgrade1 hypertension patients with Gan-Yang hyperactivity syndrome:a randomized controlled trial  

作　　者：ZHU Yushuo 朱羽硕(Dept Emerg&Critical Care Med,Affil Hosp,Shandong TCM Univ,Jinan 250014)

机构地区：[1]Dept Emerg&Critical Care Med,Affil Hosp,Shandong TCM Univ,Jinan 250014

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第4期201-201,共1页中国医学文摘(内科学分册英文版)

摘　　要：Objective To evaluate the efficacy and safety of Tengfu Jiangya Tablet(TJT)in the treatment of patients with grade 1 hypertension and Gan-Yang hyperactivity syndrome.Methods A total of 130 patients with grade 1 hypertension and Gan-Yang hyperactivity syndrome were included using a randomized,single-blind,placebocontrolled parallel design,with 65 patients in the control group and 65 patients in the experimental group.

关 键 词：PATIENTS HYPERTENSION RANDOMIZED 

分 类 号：R54[医药卫生—心血管疾病]